₹ 14994
₹420- ₹441
34
₹438
-1
3 Dec 2024
Download5 Dec 2024
6 Dec 2024
Application Details
The Suraksha Diagnostic IPO will open for subscription from November 29, 2024, to December 3, 2024. Priced between ₹420 and ₹441 per share with a face value of ₹2, the IPO follows a book-built issue format. Investors can apply for a minimum lot size of 34 shares, amounting to ₹14,994, while the maximum investment for retail investors is 13 lots (442 shares) at ₹1,94,922.
The total issue comprises 19,189,330 shares, raising up to ₹846.25 crore, all through an Offer for Sale (OFS). The reservation breakdown allocates up to 50% of the net offer for Qualified Institutional Buyers (QIBs), at least 35% for retail investors, and 15% for Non-Institutional Investors (NIIs).
Key dates for the IPO include the basis of allotment on December 4, 2024, followed by the initiation of refunds and credit of shares to demat accounts on December 5, 2024. Suraksha Diagnostic is expected to list on stock exchanges on December 6, 2024.
About Suraksha Diagnostic Limited
Company Overview
Suraksha Diagnostic Limited was incorporated in 2005. It is one of the leading pathology and radiology-based diagnostic service providers with an operational presence in West Bengal, Bihar, Assam, and Meghalaya. As of June 30, 2024, Suraksha has a strong network comprising one Central Reference Laboratory, eight Satellite laboratories, 49 Diagnostic Centres, and 166 Sample Collection Centres, aggregating 215 customer touchpoints. This also offers online and offline medical consultation services through 44 diagnostic centres housing over 750 doctors across 120 polyclinics.
Service Offerings
Integrated Diagnostics: Suraksha offers a full suite of over 2,300 diagnostic tests, including:
- Pathology: 788 routine and 664 specialized tests such as molecular pathology and advanced biochemistry.
- Radiology: 766 basic/intermediate tests, including X-rays and CT scans, and 119 advanced tests like MRI and specialized CT scans.
Value-Added Services:
- Holistic medical consultancy services across specialities like cardiology, paediatrics, and oncology.
- Customized test packages for disease prediction and early detection.
- Vaccination services to promote preventive healthcare.
Technological Innovations:
The company implements some sophisticated systems: LIMS, RIS, PACS, and ERP to ensure smooth operations. All radiology reporting is done digitally; this enables quicker diagnosis and turnaround times.
FAQ
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.